Evidence map›Paper›PMID 35323375›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.

Alessandra Buja, Massimo Rugge, Giuseppe De Luca, Emanuela Bovo, Manuel Zorzi, Chiara De Toni, Claudia Cozzolino, Antonella Vecchiato, Paolo Del Fiore, Romina Spina and 4 more

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Alessandra BujaDepartment of Cardiologic, Vascular and Thoracic Sciences and Public Health, University of Padua, 35131 Padua, Italy.ORCID 0000-0003-2216-3807
Massimo RuggePathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua, 35131 Padua, Italy.
Giuseppe De LucaDepartment of Cardiologic, Vascular and Thoracic Sciences and Public Health, University of Padua, 35131 Padua, Italy.ORCID 0000-0002-3970-3286
Emanuela BovoAzienda Zero, Veneto Tumor Registry (RTV), 35131 Padua, Italy.
Manuel ZorziAzienda Zero, Veneto Tumor Registry (RTV), 35131 Padua, Italy.ORCID 0000-0001-6025-5214
Chiara De ToniDepartment of Statistical Sciences, University of Padua, 35131 Padua, Italy.
Claudia CozzolinoSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35131 Padua, Italy.ORCID 0000-0001-7628-9515
Antonella VecchiatoSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35131 Padua, Italy.
Paolo Del FioreDepartment of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35131 Padua, Italy.ORCID 0000-0002-2862-8014
Romina SpinaDepartment of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35131 Padua, Italy.
Sandro CinquettiHygiene and Public Health Service (SISP), Azienda ULSS 1 Dolomiti, 32100 Belluno, Italy.
Vincenzo BaldoDepartment of Cardiologic, Vascular and Thoracic Sciences and Public Health, University of Padua, 35131 Padua, Italy.ORCID 0000-0001-6012-9453
Carlo Riccardo RossiSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35131 Padua, Italy.
Simone MocellinSoft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35131 Padua, Italy.
University of Padua · ITIstituto Oncologico Veneto · ITRegione del Veneto · ITAULSS 2 Marca Trevigiana · IT

Funding

Fondazione Cassa di Risparmio di Padova e Rovigo bando 2019
6 · The paper itself

Abstract

Previous studies associated high-level exposure to ultraviolet radiation with a greater risk of cutaneous malignant melanoma (CMM). This study focuses on the changing incidence of CMM over time (from 1990 to 2017) in the Veneto region of Northeast Italy, and its Alpine area (the province of Belluno). The clinicopathological profile of CMM by residence is also considered. A joinpoint regression analysis was performed to identify significant changes in the yearly incidence of CMM by sex and age. For each trend, the average annual percent change (AAPC) was also calculated. In the 2017 CMM cohort, the study includes a descriptive analysis of the disease's categorical clinicopathological variables. In the population investigated, the incidence of CMM has increased significantly over the last 30 years. The AAPC in the incidence of CMM was significantly higher among Alpine residents aged 0-49 than for the rest of the region's population (males: 6.9 versus 2.4; females 7.7 versus 2.7, respectively). Among the Alpine residents, the AAPC was 3.35 times greater for females aged 0-49 than for people aged 50+. The clinicopathological profile of CMM was significantly associated with the place of residence. Over three decades, the Veneto population has observed a significant increase in the incidence of CMM, and its AAPC. Both trends have been markedly more pronounced among Alpine residents, particularly younger females. While epidemiology and clinicopathological profiles support the role of UV radiation in CMM, the young age of this CMM-affected female population points to other possible host-related etiological factors. These findings also confirm the importance of primary and secondary prevention strategies.

Indexed as

MelanomaSkin NeoplasmsCutaneous Malignant MelanomaFemaleHumansIncidenceMaleUltraviolet Raysincidencejoinpointmelanomamountain residentsspatial analysissun exposuretemporal trendsultraviolet radiationUVR

Identifiers

PMID35323375
PMCPMC8947100
OpenAlexW4220964539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.